L. Pache

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

F. Jänicke, Manfred Schmitt, L. Pache et al. · Breast Cancer Research and Treatment · 1993 · 359 citations

Inhibitor Pai-1, Oncology, Breast Oncology +10

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up

Nadia Harbeck, Michael Untch, L. Pache et al. · British Journal of Cancer · 1994 · 220 citations · Full text

Breast Oncology, Cancer Detection, Breast Cancer Patients +10

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer

F. Jänicke, A. Search Holscher, Walther Kuhn et al. · Cancer · 1992 · 194 citations · Full text

Urokinase (uPA) and PAI-1 Predict Survival in Advanced Ovarian Cancer Patients (FIGO III) after Radical Surgery and Platinum-Based Chemotherapy

W. Kühn, L. Pache, Barbara Schmalfeldt et al. · Gynecologic Oncology · 1994 · 139 citations

Urology, Surgical Oncology, Pai-1 Predict Survival +9

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

W. Kühn, Barbara Schmalfeldt, Ute Reuning et al. · British Journal of Cancer · 1999 · 130 citations · Full text